CORIOLUS MRL is a biomass containing both mycelium and active components of coriolus versicolor grown under aseptic conditions. Mycology Research Loboratories (MRL) uses patented production technology to cultivate the fungus coriolus versicolor in California. Benefits of administration: It contributes to the improvement of symptoms in people with immunodeficiency, oncological diseases, HPV infections, recurrent genital infections, hepatitis type B or C and EBV infections, neurological diseases, chronic fatigue syndrome, viral infections. Administration: Adults - 6 tablets (3g) Coriolus-MRL per day, (3 tablets in the morning and 3 tablets in the evening 30 minutes before meals) for 12 weeks. Packaging size: 90 tablets